Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Depreciation & Amortization (CF) (2010 - 2020)

Grifols' (GRFS) quarterly Depreciation & Amortization (CF) came in at $85.6 million in Q1 2020, up 1.15% YoY from $84.7 million in Q2 2019, and down 65.48% on a QoQ basis from $248.1 million in Q4 2019.

Grifols (GRFS) Depreciation & Amortization (CF) (2010 - 2020) Analysis & Trends

Grifols (GRFS) has 11 years of Depreciation & Amortization (CF) data on file, last reported at $85.6 million in Q1 2020.

  • Quarterly Depreciation & Amortization (CF) rose 1.15% year-over-year to $85.6 million in Q1 2020, while the trailing twelve-month figure through Dec 2021 was $85.6 million (down 74.34% YoY) and the FY2021 annual result came in at $411.6 million, up 12.11% from the prior year.
  • Depreciation & Amortization (CF) fell to $85.6 million in Q1 2020, from $248.1 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.4 billion in Q2 2017 to a low of $55.6 million in Q3 2016.
  • A 5-year average of $451.9 million and a median of $186.5 million in 2017 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2017 — Depreciation & Amortization (CF) slumped 95.29% — and 2019, when it jumped 30.64%.
  • Tracing GRFS's Depreciation & Amortization (CF) over 5 years: stood at $1.4 billion in 2016, then tumbled by 86.64% to $186.5 million in 2017, then advanced by 1.84% to $189.9 million in 2018, then surged by 30.64% to $248.1 million in 2019, then tumbled by 65.48% to $85.6 million in 2020.
  • The last three Depreciation & Amortization (CF) figures came in at $85.6 million (Q1 2020), $248.1 million (Q4 2019), and $84.7 million (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 1.96 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 1.62 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Grifols 5.45 Bn 4.45 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 85.64 Mn
Mar 31, 2020 85.64 Mn
Dec 31, 2019 248.08 Mn
Dec 31, 2019 248.08 Mn
Mar 31, 2019 84.66 Mn
Mar 31, 2019 84.66 Mn
Dec 31, 2018 189.89 Mn
Dec 31, 2018 189.89 Mn
Mar 31, 2018 64.97 Mn
Mar 31, 2018 64.97 Mn
Dec 31, 2017 186.46 Mn
Dec 31, 2017 186.46 Mn
Jun 30, 2017 1.40 Bn
Jun 30, 2017 1.40 Bn
Mar 31, 2017 56.80 Mn
Mar 31, 2017 56.80 Mn
Dec 31, 2016 1.40 Bn
Dec 31, 2016 1.40 Bn
Sep 30, 2016 55.63 Mn
Sep 30, 2016 55.63 Mn